Literature DB >> 26890293

Short-Term and Long-Term Reproducibility of Hypertension Phenotypes Obtained by Office and Ambulatory Blood Pressure Measurements.

Alejandro de la Sierra1, Ernest Vinyoles2, José R Banegas3, Gianfranco Parati4, Juan J de la Cruz3, Manuel Gorostidi5, Julián Segura6, Luis M Ruilope6.   

Abstract

The authors aimed to assess the reproducibility of normotension and white-coat, masked, and sustained hypertension in 839 untreated patients who underwent two separate assessments (median, 3; interquartile range, 0-13 months) by both office and ambulatory blood pressure (BP) monitoring (ABPM). The proportion of patients falling into the same category in the two assessments was: 52% normotension and 55% white-coat, 47% masked, and 82% sustained hypertension. The most frequent switch was to sustained hypertension (26% of white-coat and 33% of masked hypertension). No clinical factors predicted the change in category, except for higher office diastolic BP in patients with masked hypertension who developed sustained hypertension, compared with those who remained with masked hypertension (84±4 mm Hg vs 80±5 mm Hg; P=.006). The reproducibility of hypertension phenotypes was highly dependent on the time between assessments. The authors conclude that white-coat and masked hypertension phenotypes are only reproducible in the short-term, while they frequently shift towards sustained hypertension in the long-term.
© 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2016        PMID: 26890293      PMCID: PMC8032105          DOI: 10.1111/jch.12792

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  17 in total

1.  Long-term risk of sustained hypertension in white-coat or masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Rita Facchetti; Fabiana Madotto; Fosca Quarti-Trevano; Hernan Polo Friz; Guido Grassi; Roberto Sega
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

2.  Short- and long-term incidence of stroke in white-coat hypertension.

Authors:  Paolo Verdecchia; Gian Paolo Reboldi; Fabio Angeli; Giuseppe Schillaci; Joseph E Schwartz; Thomas G Pickering; Yutaka Imai; Takayoshi Ohkubo; Kazuomi Kario
Journal:  Hypertension       Date:  2004-12-13       Impact factor: 10.190

3.  Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.

Authors:  Elizabeth S Muxfeldt; Roberto Fiszman; Fabio de Souza; Bianca Viegas; Fernanda C Oliveira; Gil F Salles
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

4.  Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

Authors:  Alejandro de la Sierra; Julián Segura; José R Banegas; Manuel Gorostidi; Juan J de la Cruz; Pedro Armario; Anna Oliveras; Luis M Ruilope
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

5.  Maximum likelihood estimation for the beta-binomial distribution and an application to the household distribution of the total number of cases of a disease.

Authors:  D A Griffiths
Journal:  Biometrics       Date:  1973-12       Impact factor: 2.571

6.  Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients.

Authors:  Alejandro de la Sierra; Josep Redon; José R Banegas; Julián Segura; Gianfranco Parati; Manuel Gorostidi; Juan J de la Cruz; Javier Sobrino; José L Llisterri; Javier Alonso; Ernest Vinyoles; Vicente Pallarés; Antonio Sarría; Pedro Aranda; Luis M Ruilope
Journal:  Hypertension       Date:  2009-01-26       Impact factor: 10.190

Review 7.  Masked hypertension: a systematic review.

Authors:  Guillaume Bobrie; Pierre Clerson; Joël Ménard; Nicolas Postel-Vinay; Gilles Chatellier; Pierre-François Plouin
Journal:  J Hypertens       Date:  2008-09       Impact factor: 4.844

8.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

9.  Clinical characteristics of isolated clinic hypertension.

Authors:  Ernest Vinyoles; Angela Felip; Enriqueta Pujol; Alejandro de la Sierra; Rafael Durà; Raquel Hernández del Rey; Javier Sobrino; Manuel Gorostidi; Mariano de la Figuera; Julián Segura; José R Banegas; Luis Miguel Ruilope
Journal:  J Hypertens       Date:  2008-03       Impact factor: 4.844

10.  Short-Term and Long-Term Reproducibility of Hypertension Phenotypes Obtained by Office and Ambulatory Blood Pressure Measurements.

Authors:  Alejandro de la Sierra; Ernest Vinyoles; José R Banegas; Gianfranco Parati; Juan J de la Cruz; Manuel Gorostidi; Julián Segura; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-18       Impact factor: 3.738

View more
  15 in total

1.  Blood pressure phenotype reproducibility in CKD outpatients: a clinical practice report.

Authors:  Adamasco Cupisti; R M Bruno; A Puntoni; E Varricchio; E Giglio; O Meniconi; C Zullo; M Barsotti; M F Egidi; L Ghiadoni
Journal:  Intern Emerg Med       Date:  2019-06-17       Impact factor: 3.397

2.  Short-Term Reproducibility of Masked Hypertension Among Adults Without Office Hypertension.

Authors:  Laura P Cohen; Joseph E Schwartz; Daniel N Pugliese; D Edmund Anstey; Jessica P Christian; Stephanie Jou; Paul Muntner; Daichi Shimbo; Natalie A Bello
Journal:  Hypertension       Date:  2020-09-09       Impact factor: 10.190

3.  Masked Hypertension: Fragile in More Ways Than One.

Authors:  Jordana B Cohen
Journal:  Hypertension       Date:  2020-09-09       Impact factor: 10.190

Review 4.  White Coat Hypertension: to Treat or Not to Treat?

Authors:  Cesare Cuspidi; Carla Sala; Guido Grassi; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2016-11       Impact factor: 5.369

5.  Reproducibility of masked uncontrolled hypertension detected through home blood pressure monitoring.

Authors:  Jessica Barochiner; María Lourdes Posadas Martínez; Rocío Martínez; Diego Giunta
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-19       Impact factor: 3.738

6.  New vascular biomarkers related to ABPM phenotypes in untreated patients.

Authors:  Luis M Ruilope; Gema Ruiz-Hurtado
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-07       Impact factor: 3.738

7.  Short-Term and Long-Term Reproducibility of Hypertension Phenotypes Obtained by Office and Ambulatory Blood Pressure Measurements.

Authors:  Alejandro de la Sierra; Ernest Vinyoles; José R Banegas; Gianfranco Parati; Juan J de la Cruz; Manuel Gorostidi; Julián Segura; Luis M Ruilope
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-02-18       Impact factor: 3.738

8.  Predictors of high central blood pressure in young with isolated systolic hypertension.

Authors:  G D Radchenko; O O Torbas; Yu M Sirenko
Journal:  Vasc Health Risk Manag       Date:  2016-08-02

9.  Masked Hypertension: An Independent Cardiovascular Risk Factor or a Facet of True Blood Pressure Level?

Authors:  Antti Jula
Journal:  J Am Heart Assoc       Date:  2016-03-29       Impact factor: 5.501

10.  Association between blood pressure categories and cardiovascular disease mortality in China.

Authors:  Jie Guo; Jun Lv; Yu Guo; Zheng Bian; Bang Zheng; Man Wu; Ling Yang; Yiping Chen; Jian Su; Jianqiang Zhang; Jvying Yao; Junshi Chen; Zhengming Chen; Canqing Yu; Liming Li
Journal:  PLoS One       Date:  2021-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.